Lucy Ryan1,2, Elena Provenzano3,4, Anita Grigoriadis1,2,5

  • 1Cancer Bioinformatics, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.

The Journal of pathology
|October 24, 2025
PubMed
概括

在新辅助化疗 (NACT) 后评估乳腺癌淋巴结需要改进. 更详细的病理分析可以提高患者分层和治疗策略.